Back to today’s briefing

Story perspectives

Semaglutide Cuts Dementia Risk by 50%, Study Finds

6/25/2025

34 8

Summary

Story summary

A groundbreaking study from Case Western Reserve University reveals that semaglutide, a medication for type 2 diabetes, could slash the risk of dementia by 40-50%, especially Alzheimer's and vascular dementia. Analyzing 1.7 million patient records, researchers are hopeful but stress that further clinical trials are essential to validate these promising results.

1 of 1

Story summary

A groundbreaking study from Case Western Reserve University reveals that semaglutide, a medication for type 2 diabetes, could slash the risk of dementia by 40-50%, especially Alzheimer's and vascular dementia. Analyzing 1.7 million patient records, researchers are hopeful but stress that further clinical trials are essential to validate these promising results.